跳至主要内容
临床试验/NL-OMON54839
NL-OMON54839招募中不适用

A randomised controlled trial comparing endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding (MIRA 2 trial). - MIRA 2 trial

Maxima Medisch Centrum0 个研究点目标入组 718 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
718

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Women suffering from heavy menstrual bleeding, who opt for treatment with EA,
  • irrespective of the existence of fibroids, polyps or adenomyosis.

排除标准

  • - Women who don*t speak Dutch or English to a standard that they can fully
  • understand the study and complete the trial questionnaires.
  • - Women with a (future) childwish
  • - Women with a suspicion on endometrial cancer.
  • - Women with contra-indications for levonorgestrel IUD.
  • - Women with an already performed Endometrial Ablation.
  • - Women over 60 years old.

研究者

发起方
Maxima Medisch Centrum

相似试验

A randomised controlled trial comparing endometrial... | 临床试验